Related Experiment Video
Updated: Apr 19, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
β₂ adrenergic receptor activation suppresses bone morphogenetic protein (BMP)-induced alkaline phosphatase expression
Takayuki Yamada1, Yoichi Ezura, Tadayoshi Hayata
1Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan; Global COE Program, Tokyo Medical and Dental University, Tokyo, Japan.
Abstract:
β adrenergic stimulation suppresses bone formation in vivo while its actions in osteoblastic differentiation are still incompletely understood. We therefore examined the effects of β2 adrenergic stimulation on osteoblast-like MC3T3-E1 cells focusing on BMP-induced alkaline phosphatase expression. Morphologically, isoproterenol treatment suppresses BMP-induced increase in the numbers of alkaline phosphatase-positive small foci in the cultures of MC3T3-E1 cells. Biochemically, isoproterenol treatment suppresses BMP-induced enzymatic activity of alkaline phosphatase in a dose-dependent manner. Isoproterenol suppression of alkaline phosphatase activity is observed even when the cells are treated with high concentrations of BMP. With respect to cell density, isoproterenol treatment tends to suppress BMP-induced increase in alkaline phosphatase expression more in osteoblasts cultured at higher cell density. In terms of treatment protocol, continuous isoproterenol treatment is compared to cyclic treatment. Continuous isoproterenol treatment is more suppressive against BMP-induced increase in alkaline phosphatase expression than cyclic regimen. At molecular level, isoproterenol treatment suppresses BMP-induced enhancement of alkaline phosphatase mRNA expression. Regarding the mode of isoproterenol action, isoproterenol suppresses BMP-induced BRE-luciferase activity. These data indicate that isoproterenol regulates BMP-induced alkaline phosphatase expression in osteoblast-like MC3T3E1 cells.
Insights
Beta-2 adrenergic stimulation, using isoproterenol, inhibits bone formation markers in osteoblast cells. This beta-2 adrenergic action suppresses alkaline phosphatase expression, a key indicator of bone development.
Area of Science:
- Bone Biology and Osteoblast Differentiation
- Adrenergic Signaling Pathways
- Cellular and Molecular Physiology
Background:
- Beta-adrenergic stimulation is known to inhibit bone formation in vivo.
- The precise mechanisms by which beta-adrenergic signaling influences osteoblast differentiation remain unclear.
- Understanding these effects is crucial for bone health research.
Purpose of the Study:
- To investigate the impact of beta-2 adrenergic stimulation on osteoblast-like MC3T3-E1 cells.
- To specifically examine the effects on alkaline phosphatase expression induced by Bone Morphogenetic Proteins (BMPs).
- To elucidate the molecular pathways involved in this regulation.
Main Methods:
- Utilized MC3T3-E1 cells, a common model for osteoblast differentiation.
- Administered isoproterenol (a beta-2 adrenergic agonist) and BMPs to cell cultures.
- Assessed alkaline phosphatase activity and mRNA expression.
- Measured BMP-responsive element (BRE)-luciferase activity to study signaling pathways.
Main Results:
- Isoproterenol significantly suppressed BMP-induced alkaline phosphatase expression in a dose-dependent manner.
- Suppression was more pronounced at higher cell densities and with continuous isoproterenol treatment.
- Isoproterenol reduced alkaline phosphatase mRNA levels and inhibited BMP-induced BRE-luciferase activity.
- These effects were observed even with high BMP concentrations.
Conclusions:
- Beta-2 adrenergic stimulation, via isoproterenol, negatively regulates BMP-induced alkaline phosphatase expression in osteoblast-like cells.
- The mechanism involves interference with BMP signaling pathways at the transcriptional level.
- These findings contribute to understanding the role of adrenergic signaling in bone metabolism and osteoblast function.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Enzymatic Cascade
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Cell Specific Gene Expression

